AR
Assura Plc
ARSSF · OTC
$0.68 +0.00% (+$0.00)
Market Cap £1.64B
P/E Ratio 9.51x
Div. Yield 3.29%
ROE 10.64%
Bulios Fair Price
$0.92
35.7% upside
Current Price
$0.68
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ARSSF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
5/9Valuation
90 /100
Cheap P/B 1.00x
P/FCF 17.86x
P/S 8.91x
Growth
94 /100
Growing FCF growth 42.16%
Book val. growth 6.82%
Rev. growth 10.49%
Profitability
100 /100
Strong Net margin 90.32%
Op. margin 82.70%
FCF margin 49.89%
Quality
60 /100
Average ROE 10.64%
ROA 5.06%
Asset turnover 0.06x
Debt
76 /100
Low Current ratio 0.73x
Int. coverage 4.99x
Debt/Assets 0.47x
Stability
58 /100
Moderate Rev. volatility 2.56%
EPS volatility 117.01%
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ARSSF
Online
Sector
Real Estate
Industry
REIT - Healthcare Facilities
CEO
Jonathan Stewart Murphy
Employees
84
Headquarters
Warrington
Upcoming events
12 NOV
Earnings
Upcoming earnings report